Difference between revisions of "MRE Biomarker Ctte"
Jump to navigation
Jump to search
| Line 14: | Line 14: | ||
'''Approved call summaries:''' | '''Approved call summaries:''' | ||
| + | *[[Media:2018_11-20_QIBA_MRE_BC_Call_Summary-FINAL.pdf|November 20, 2018]] | ||
*[[Media:2018_04-09_QIBA_MRE_BC_Call_Summary-FINAL.pdf|April 9, 2018]] | *[[Media:2018_04-09_QIBA_MRE_BC_Call_Summary-FINAL.pdf|April 9, 2018]] | ||
*[[Media:2017_01-30_QIBA_MRE_BC_Call_Summary-FINAL.pdf|January 30, 2017]] | *[[Media:2017_01-30_QIBA_MRE_BC_Call_Summary-FINAL.pdf|January 30, 2017]] | ||
| − | |||
'''''[[MRE BC Call Summaries Archive]]''''' | '''''[[MRE BC Call Summaries Archive]]''''' | ||
Revision as of 15:48, 2 April 2019
- Co-chairs: Richard L. Ehman, MD; Patricia Cole, PhD, MD
- Secretary: Susan Stanfa
Project Snapshot
The MRE Biomarker Committee seeks to develop a quantitative Profile for MRE.
MRE Profile to be data-driven:
- focusing on the characterization of bias and precision in MRE measurement targets for achieving these measurements
- focusing on issues important to specific reproducibility
Meetings
Approved call summaries:
MRE Profile Development